Yikai Xu
Vice President, Strategy & Asia Business Development
Mr. Yikai Xu is a founding member of Heranova Lifesciences since 2021 and currently serves as Vice President of Strategy and Asia Business Development, where he is responsible for driving the overall portfolio strategy, commercialization strategy, and Aisa business development.
Mr. Xu was previously Associate Principal/Partner at IQVIA (Formerly IMS Health), a leading global data and strategy service provider specializing in healthcare. During his 8 years tenure at IQVIA, Mr. Xu led the portfolio and commercialization strategy development for both multinational and early-stage life science companies across different therapeutic areas and geographic markets.
Mr. Xu holds a master’s degree from Northwestern University and had 6+ years of experience in wet lab research.
Mr. Xu was previously Associate Principal/Partner at IQVIA (Formerly IMS Health), a leading global data and strategy service provider specializing in healthcare. During his 8 years tenure at IQVIA, Mr. Xu led the portfolio and commercialization strategy development for both multinational and early-stage life science companies across different therapeutic areas and geographic markets.
Mr. Xu holds a master’s degree from Northwestern University and had 6+ years of experience in wet lab research.